…
Solesence, Inc., a science-driven company, provides engineered materials, formulation development, and commercial manufacturing services in the United States. The company engages in the manufacture and supply of surface engineered zinc oxide and titanium dioxide ingredients. It also provides skin care formulations with mineral-based UV protection enabled by proprietary active pharmaceutical ingredients; and skin health products, such as sunscreens and daily care products. The company sells products in various markets, including medical diagnostics, architectural coatings, industrial coating applications, abrasion-resistant additives, and plastics additives applications. It serves skin health, beauty, and wellness sectors. The company was formerly known as Nanophase Technologies Corporation and changed its name to Solesence, Inc. in March 2025. Solesence, Inc. was incorporated in 1989 and is headquartered in Romeoville, Illinois.
Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website
A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Income before tax | 1.86M | 4.46M | -4.38M | -2.64M | 2.36M |
| Net income | 1.79M | 4.24M | -4.39M | -2.62M | 2.32M |
| Selling general administrative | 10.40M | 7.22M | 7.53M | 7.58M | 3.90M |
| Gross profit | 16.03M | 16.19M | 7.83M | 8.36M | 8.69M |
| Reconciled depreciation | 0.90M | 0.93M | 0.74M | 0.57M | 0.45M |
| Ebit | 2.79M | 5.13M | -3.55M | -2.26M | 3.51M |
| Ebitda | 3.69M | 6.06M | -2.80M | -1.69M | 3.96M |
| Depreciation and amortization | 0.90M | 0.93M | 0.74M | 0.57M | 0.45M |
| Operating income | 1.57M | 5.13M | -3.55M | -2.26M | 2.56M |
| Other operating expenses | 60.49M | 47.22M | 40.84M | 39.58M | 26.92M |
| Interest expense | 0.93M | 0.67M | 0.84M | 0.38M | 1.15M |
| Tax provision | 0.07M | 0.23M | 0.01M | -0.02M | 0.04M |
| Net interest income | -0.93M | -0.67M | -0.84M | -0.38M | -1.15M |
| Income tax expense | 0.07M | 0.23M | 0.01M | -0.02M | 0.04M |
| Total revenue | 62.06M | 52.35M | 37.30M | 37.32M | 29.48M |
| Total operating expenses | 14.46M | 11.06M | 11.37M | 10.62M | 6.13M |
| Cost of revenue | 46.04M | 36.16M | 29.47M | 28.96M | 20.79M |
| Total other income expense net | 0.29M | -0.67M | -0.84M | -0.38M | -0.20M |
| Net income from continuing ops | 1.79M | 4.24M | -4.39M | -2.62M | 2.32M |
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Total assets | 50.05M | 50.00M | 32.88M | 33.56M | 28.39M |
| Other current assets | 2.14M | 2.80M | 1.08M | 0.87M | 0.91M |
| Total liab | 32.42M | 35.06M | 30.98M | 27.91M | 20.93M |
| Total stockholder equity | 17.63M | 14.95M | 1.90M | 5.65M | 7.46M |
| Other current liab | 2.59M | 3.25M | 0.74M | 0.56M | 0.50M |
| Common stock | 0.71M | 0.70M | 0.50M | 0.49M | 0.49M |
| Capital stock | 0.71M | 0.70M | 0.50M | 0.49M | 0.49M |
| Retained earnings | -98.64M | -100.43M | -104.66M | -100.07M | -97.45M |
| Cash | 1.29M | 1.41M | 1.72M | 2.19M | 0.66M |
| Total current liabilities | 13.93M | 25.77M | 15.59M | 13.84M | 7.34M |
| Current deferred revenue | 0.93M | 5.57M | 2.35M | 2.23M | 0.91M |
| Net debt | 23.03M | 13.89M | 19.54M | 15.92M | 14.09M |
| Short term debt | 6.02M | 6.26M | 6.11M | 4.28M | 2.04M |
| Short long term debt | 4.77M | 5.00M | 4.81M | 4.28M | 1.35M |
| Short long term debt total | 24.32M | 15.30M | 21.26M | 18.11M | 14.75M |
| Other stockholder equity | 115.57M | 114.67M | 106.07M | 105.23M | 104.42M |
| Total current assets | 28.78M | 29.35M | 16.30M | 16.62M | 11.60M |
| Net receivables | 6.84M | 4.87M | 3.47M | 4.73M | 3.94M |
| Long term debt | 10.50M | - | 6.00M | 4.00M | 1.00M |
| Inventory | 18.51M | 20.27M | 10.03M | 8.84M | 6.09M |
| Accounts payable | 4.39M | 10.69M | 6.39M | 6.77M | 3.89M |
| Non currrent assets other | 14.37M | 0.00M | 0.00M | 0.01M | 0.01M |
| Non current assets total | 21.28M | 20.65M | 16.58M | 16.93M | 16.80M |
| Capital lease obligations | 9.05M | 10.30M | 10.45M | 9.82M | 12.40M |
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Investments | - | -4.56M | -1.05M | -2.82M | -1.87M |
| Total cashflows from investing activities | -2.14M | -4.56M | -1.05M | -2.82M | -1.87M |
| Net borrowings | 10.27M | -5.81M | 2.52M | 5.82M | -0.98M |
| Total cash from financing activities | 10.59M | 2.27M | 2.59M | 6.00M | -0.75M |
| Net income | 1.79M | 4.24M | -4.39M | -2.62M | 2.32M |
| Change in cash | -0.12M | -0.31M | -0.46M | 1.53M | -0.30M |
| Begin period cash flow | 1.41M | 1.72M | 2.19M | 0.66M | 0.96M |
| End period cash flow | 1.29M | 1.41M | 1.72M | 2.19M | 0.66M |
| Total cash from operating activities | -8.57M | 1.97M | -2.01M | -1.65M | 2.32M |
| Issuance of capital stock | 0.00M | 6.00M | 0.00M | - | - |
| Depreciation | 0.90M | 0.93M | 0.74M | 0.57M | 0.45M |
| Other cashflows from investing activities | -2.14M | -4.56M | - | - | - |
| Change to inventory | 1.76M | -10.24M | -1.19M | -2.74M | -1.75M |
| Change to account receivables | -1.97M | -1.40M | 1.06M | -0.80M | -1.00M |
| Other cashflows from financing activities | 10.59M | 8.08M | 0.07M | 6.11M | 0.23M |
| Capital expenditures | 2.14M | 4.56M | 1.05M | 2.82M | 1.87M |
| Change in working capital | -11.83M | -3.92M | 0.87M | -2.79M | -0.56M |
| Stock based compensation | 0.57M | 0.72M | 0.77M | 0.62M | 0.16M |
| Other non cash items | -11.83M | - | - | 2.57M | -0.05M |
| Free cash flow | -10.71M | -2.59M | -3.06M | -4.47M | 0.45M |
Sector: Consumer Defensive Industry: Household & Personal Products
|
Stock Name
|
Change
(USD) |
Price
(USD) |
Trailing
PE (x) |
Forward
PE (x) |
Price Sales
TTM (x) |
Price to Book Value (x)
|
Enterprise Value
to Revenue (x) |
Enterprise Value
to EBITDA (x) |
|---|---|---|---|---|---|---|---|---|
| SLSN Solesence, Inc. Common Stock |
- -% |
0.86 | - | 11.36 | 1.05 | 4.35 | 1.42 | 27.69 |
| PG Procter & Gamble Company |
-0.12 0.07% |
163.56 | 23.58 | 22.62 | 4.07 | 7.24 | 4.40 | 16.08 |
| LRLCF L'Oréal S.A |
4.50 0.94% |
485.50 | 41.14 | 34.25 | 6.52 | 8.59 | 6.67 | 27.76 |
| LRLCY L’Oreal Co ADR |
1.02 1.05% |
98.04 | 32.44 | 25.64 | 5.16 | 6.03 | 4.79 | 19.51 |
| UL Unilever PLC ADR |
1.18 1.81% |
66.44 | 21.53 | 16.39 | 2.66 | 7.29 | 2.77 | 12.45 |
Solesence, Inc., a science-driven company, provides engineered materials, formulation development, and commercial manufacturing services in the United States. The company engages in the manufacture and supply of surface engineered zinc oxide and titanium dioxide ingredients. It also provides skin care formulations with mineral-based UV protection enabled by proprietary active pharmaceutical ingredients; and skin health products, such as sunscreens and daily care products. The company sells products in various markets, including medical diagnostics, architectural coatings, industrial coating applications, abrasion-resistant additives, and plastics additives applications. It serves skin health, beauty, and wellness sectors. The company was formerly known as Nanophase Technologies Corporation and changed its name to Solesence, Inc. in March 2025. Solesence, Inc. was incorporated in 1989 and is headquartered in Romeoville, Illinois.
| Name | Title | Year Born |
|---|---|---|
| Mr. Kevin Cureton | President, CEO & Director | 1962 |
| Ms. Laura Riffner | Chief Financial Officer | 1972 |
Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.